NanoVibronix Cash Flow | StatInvestor

Health Care & Life Sciences » Medical Equipment & Supplies | NanoVibronix Inc.

NanoVibronix Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

1,989.00

2,647.00

2,884.00

2,831.00

4,965.00

4,154

Depreciation, Depletion & Amortization

10.00

9.00

7.00

5.00

Other Funds

1,022.00

1,047.00

1,566.00

891.00

2,546.00

889

Funds from Operations

957.00

1,591.00

1,309.00

1,933.00

2,414.00

3,259

Changes in Working Capital

355.00

691.00

171.00

400.00

232.00

291

Net Operating Cash Flow

602.00

900.00

1,480.00

1,533.00

2,182.00

3,550

Capital Expenditures

5.00

4.00

1.00

8.00

Net Investing Cash Flow

5.00

4.00

1.00

8.00

Issuance/Reduction of Debt, Net

33.00

Net Financing Cash Flow

600.00

900.00

3,005.00

33.00

6,436.00

Net Change in Cash

7.00

4.00

1,524.00

1,508.00

4,254.00

Free Cash Flow

607.00

904.00

1,481.00

1,541.00

2,182.00

Change in Capital Stock

600.00

900.00

3,005.00

6,436.00

About NanoVibronix

View Profile

Address	525 Executive Boulevard New york New York 10523 United States
Employees	-
Website	http://www.nanovibronix.com
Updated	07/08/2019
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices that target wound healing, and pain therapy and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other.